Evidence map›Paper›PMID 32039044›Full record

ArticleFrontiers in cellular and infection microbiology2019

Assessment of an Antibody-in-Lymphocyte Supernatant Assay for the Etiological Diagnosis of Pneumococcal Pneumonia in Children.

Michael J Carter, Pallavi Gurung, Claire Jones, Shristy Rajkarnikar, Rama Kandasamy, Meeru Gurung, Stephen Thorson, Madhav C Gautam, Krishna G Prajapati, Bibek Khadka and 15 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors at 6 institutions in 5 countries.

Michael J CarterOxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, United Kingdom.
Pallavi GurungPatan Academy of Health Sciences, Kathmandu, Nepal.
Claire JonesOxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, United Kingdom.
Shristy RajkarnikarPatan Academy of Health Sciences, Kathmandu, Nepal.
Rama KandasamyOxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, United Kingdom.
Meeru GurungPatan Academy of Health Sciences, Kathmandu, Nepal.
Stephen ThorsonPatan Academy of Health Sciences, Kathmandu, Nepal.
Madhav C GautamPatan Academy of Health Sciences, Kathmandu, Nepal.
Krishna G PrajapatiPatan Academy of Health Sciences, Kathmandu, Nepal.
Bibek KhadkaPatan Academy of Health Sciences, Kathmandu, Nepal.
Anju MaharjanPatan Academy of Health Sciences, Kathmandu, Nepal.
Julian C KnightWellcome Centre for Human Genetics, University of Oxford, Oxford, United Kingdom.
David R MurdochDepartment of Pathology, University of Otago, Christchurch, Christchurch, New Zealand.
Thomas C DartonOxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, United Kingdom.
Merryn VoyseyOxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, United Kingdom.
Brian WahlInternational Vaccine Access Center, Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States.
Katherine L O'BrienInternational Vaccine Access Center, Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States.
Sarah KellyOxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, United Kingdom.
Imran AnsariPatan Academy of Health Sciences, Kathmandu, Nepal.
Ganesh ShahPatan Academy of Health Sciences, Kathmandu, Nepal.
Nina EkströmExpert Microbiology Unit, National Institute for Health and Welfare (THL), Helsinki, Finland.
Merit MelinExpert Microbiology Unit, National Institute for Health and Welfare (THL), Helsinki, Finland.
Andrew J PollardOxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, United Kingdom.
Dominic F KellyOxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, United Kingdom.
Shrijana ShresthaPatan Academy of Health Sciences, Kathmandu, Nepal.
Patan Academy of Health Sciences · NPUniversity of Oxford · GBOxford BioMedica (United Kingdom) · GBFinnish Institute for Health and Welfare · FIJohns Hopkins University · USUniversity of Otago · NZ

Funding

Wellcome TrustWellcome Trust 104439/Z/14/Z
6 · The paper itself

Abstract

New diagnostic tests for the etiology of childhood pneumonia are needed. We evaluated the antibody-in-lymphocyte supernatant (ALS) assay to detect immunoglobulin (Ig) G secretion from

Indexed as

AdolescentAntibodies, BacterialAntigens, BacterialBacterial ProteinsChildChild, PreschoolC-Reactive ProteinDiagnostic Tests, RoutineFemaleHumansImmunoglobulin GImmunologic TestsInfantLeukocytes, MononuclearLymphocytesMaleAntibodies, BacterialAntigens, BacterialBacterial ProteinsC-Reactive ProteinImmunoglobulin Gantibodiesdiagnostic test (MeSH)lymphocytespneumococcus (Streptococcus pneumoniae)pneumonia

Identifiers

PMID32039044
PMCPMC6988833
OpenAlexW2999855317

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.